Concepedia

Publication | Closed Access

A phase 1 study of the MDM2 antagonist RO6839921, a pegylated prodrug of idasanutlin, in patients with advanced solid tumors

DOI

18

Citations

8

References

2019

Year

Albiruni R. Abdul Razak, Wilson H. Miller, Geoffrey L. Uy, Steven Blotner, Anne-Marie Young, Brian Higgins, Lin-Chi Chen, Lia Gore
Investigational New Drugs

References

YearCitations

Page 1